Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories
global-intravenous-immunoglobulin-market

Global Intravenous Immunoglobulin Market [By Application (Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Hypogammaglobulinemia, Congenital AIDS, Immunodeficiency diseases, Multifocal motor neuropathy, Myasthenia Gravis, Chronic Lymphocytic Leukemia, Kawasaki disease, Guillain-Barre syndrome, and Idiopathic Thrombocytopenic Purpura (ITP)); and by Regions]: Market size & Forecast, 2018 – 2026

Published: May 2018
Pages: 90
Format: PDF
Report ID: PM1297
License and Pricing
Buy Now Inquire Before Buying

Report Summary

The Global Intravenous Immunoglobulin Market Size was estimated at USD 8,820.44 Million in 2017 and is anticipated to gain significant traction over coming years.

Immunoglobulin denotes the analysis of blood plasma containing antibody. Intravenous Immunoglobulin (IVIG) is a product which is administered intravenously. IVIG comprises polyvalent IgG antibodies that are extracted from a number of blood donor’s plasma. In general, the intravenous immunoglobulin treatment is given to the individuals who are suffering from common variable immunodeficiency due to the insufficient amount of antibodies such as X-linked agammaglobulinemia (XLA), Wiskott Aldrich Syndrome, and other forms of hypogammaglobulinemia. This treatment aids patient by maintaining the proper amount of antibodies in the body.

The global intravenous immunoglobulin market is driven by increasing occurrence of immunodeficiency. For instance, according to one industry reports, acquired immunodeficiency is a type of congenital immunodeficiency. Moreover, approximately 50,000 new cases of congenital immunodeficiency are diagnosed in the U.S. each year. In addition, according to the World Health Organization (WHO) 2016, approximately 36.7 million people are living with HIV globally. Thus, increasing prevalence of such cases demanding appropriate treatment and upsurge in the use of immunoglobulins to treat inflammatory myopathies, GuillainBarre syndrome or specific antibody deficiency is anticipated to boost the market growth. Additionally, the rise in the authorization of intravenous immunoglobulin (IVIG) drugs from the government as well as organizations such as European Medicine Agency (EMA), and Food and Drug Administration (FDA) is anticipated to boost the sales of immunoglobulin. Growing in the elderly population and developed IVIG production due to the development of technological advancement are the other key factors that contributing to the intravenous immunoglobulin market growth.

However, strict government policies and high cost associated with the therapy, and side effects with the use of IVIG are factors hampering the market growth.

North America Intravenous Immunoglobulin Market Share by Application, 2017 - 2026 (USD Million)

North America Intravenous Immunoglobulin Market Share by Application, 2017 - 2026

Inside circle shown for 2017 & outside circle shown for 2026

Segment Analysis

The global Intravenous Immunoglobulin Market is segmented on the basis of Application and geography. On the basis of application, the global Intravenous Immunoglobulin Market is categorized into Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Hypogammaglobulinemia, Congenital AIDS, Immunodeficiency diseases, Multifocal motor neuropathy, Myasthenia Gravis, Chronic Lymphocytic Leukemia, Kawasaki disease, Guillain-Barre syndrome, and Idiopathic Thrombocytopenic Purpura (ITP).

In 2017, Hypogammaglobulinemia is estimated to dominate the application segment. The dominance is attributed to the growing global occurrences of primary immunodeficiency diseases (PID). It is the most common chronic immune defect in patients with lymphoproliferative disorders (LPDs). According to the Centers for Disease Control and Prevention (CDC) in 2012, the global occurrence rate of hypogammaglobulinemia was around 2 per 100,000 populations moreover, the number of people suffering this type of disease is estimated to increase during the forecast period. Growing occurrence of immunodeficiency disorders associated with the high implementation of IVIG therapies is expected to drive the segment growth significantly.

Regional Analysis

In terms of geography, North America is estimated to dominate the global Intravenous Immunoglobulin Market. Increasing healthcare expenditure, growing level of consciousness for the products involved in the treatment of immunodeficiency disorders, and rising inclination of clinicians towards immunodeficiency therapies are the key factors attributing towards the market growth. Rising elderly population and changing lifestyle susceptible to chronic diseases are some of the factors contributing to the growth the intravenous immunoglobulin market growth in this region. Additionally, growing occurrences of primary immunodeficiency (PID) is anticipated to enhance the market growth in North America. According to American Autoimmune Related Disease Association Inc. (AARDA) 2012, approximately 50 million Americans were diagnosed to have autoimmune diseases and the number of people suffering this disease is expected to increase during the forecast period further bolstering the market growth.

North America Intravenous Immunoglobulin Market, by Application, 2017 - 2026 (USD Million)

North America Intravenous Immunoglobulin Market, by Application, 2017 - 2026

Competitive Landscape

Major firms are focusing on small firms with a working methodology of securing the end goal to manage position in the market and are associated with mergers and acquisitions, key joint efforts, and novel item advancement to pick up profit share in the business. Some major key players in global Intravenous Immunoglobulin Market are Baxter International Inc., CSL Ltd., Grifols S.A, Octapharma AG, Kedrion Biopharma Inc., LFB group, Biotest AG, China Biologics Products, Inc., BDI Pharma Inc., and Bayer Healthcare among others.

Key questions answered by the report

  • What is the current Market Size and Forecasts of Intravenous Immunoglobulin Market?
  • What is the market opportunity for Intravenous Immunoglobulin Market?
  • How big is the market size for consulting services for Intravenous Immunoglobulin Market?
  • How much is the estimated market for Theranostics in North America in the forecast period?
  • What are the available opportunities and who are the top market players in this space?
  • Which are the major application segments and what traction are they gaining in the market?

Table of Contents

  1. Overview and Scope
    1. Research goal & scope
    2. Research assumptions
    3. Research Methodology
      1. Primary data sources
      2. Secondary data sources
    4. Key take-aways
    5. Stakeholders
  2. Executive Summary
    1. Market Definition
    2. Market Segmentation
  3. Intravenous Immunoglobulin Market Insights
    1. Intravenous Immunoglobulin – Industry snapshot
    2. Intravenous Immunoglobulin - Ecosystem analysis
    3. Intravenous Immunoglobulin Market dynamics
      1. Intravenous Immunoglobulin – Market Forces
        1. Intravenous Immunoglobulin Market driver analysis
        2. Intravenous Immunoglobulin Market restraint/challenges analysis
        3. Intravenous Immunoglobulin Market opportunity analysis
    4. Industry analysis - Porter's five force
      1. Bargaining power of supplier
      2. Bargaining power of buyer
      3. Threat of substitute
      4. Threat of new entrant
      5. Degree of competition
    5. Intravenous Immunoglobulin Market PEST analysis, 2017
      1. Intravenous Immunoglobulin Industry trends
      2. Competitive Ranking Analysis
  4. Intravenous Immunoglobulin Market Size and Forecast by Application
    1. Key findings
    2. Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
      1. Global market estimates and forecasts, 2017 - 2026
    3. Hypogammaglobulinemia
      1. Global market estimates and forecasts, 2017 - 2026
    4. Congenital AIDS
      1. Global market estimates and forecasts, 2017 - 2026
    5. Immunodeficiency diseases
      1. Global market estimates and forecasts, 2017 - 2026
    6. Multifocal motor neuropathy
      1. Global market estimates and forecasts, 2017 - 2026
    7. Myasthenia Gravis
      1. Global market estimates and forecasts, 2017 - 2026
    8. Chronic Lymphocytic Leukemia
      1. Global market estimates and forecasts, 2017 - 2026
    9. Kawasaki disease
      1. Global market estimates and forecasts, 2017 - 2026
    10. Guillain-Barre syndrome
      1. Global market estimates and forecasts, 2017 - 2026
    11. Idiopathic Thrombocytopenic Purpura (ITP)
      1. Global market estimates and forecasts, 2017 - 2026
  5. Intravenous Immunoglobulin Market Size and Forecast by Regions
    1. Key findings
    2. North America
      1. Intravenous Immunoglobulin Market by Application, 2017 - 2026
      2. U.S.
        1. Intravenous Immunoglobulin Market by Application, 2017 - 2026
      3. Canada
        • Intravenous Immunoglobulin Market by Application, 2017 - 2026
    3. Europe
      1. Intravenous Immunoglobulin Market by Application, 2017 - 2026
      2. Germany
        1. Intravenous Immunoglobulin Market by Application, 2017 - 2026
      3. UK
        1. Intravenous Immunoglobulin Market by Application, 2017 - 2026
      4. France
        1. Intravenous Immunoglobulin Market by Application, 2017 - 2026
      5. Italy
        1. Intravenous Immunoglobulin Market by Application, 2017 - 2026
    4. Asia Pacific
      1. Intravenous Immunoglobulin Market by Application, 2017 - 2026
      2. China
        • Intravenous Immunoglobulin Market by Application, 2017 - 2026
      3. India
        1. Intravenous Immunoglobulin Market by Application, 2017 - 2026
      4. Japan
        1. Intravenous Immunoglobulin Market by Application, 2017 - 2026
      5. Australia
        1. Intravenous Immunoglobulin Market by Application, 2017 - 2026
    5. Latin America
      1. Intravenous Immunoglobulin Market by Application, 2017 - 2026
      2. Brazil
        • Intravenous Immunoglobulin Market by Application, 2017 - 2026
      3. Mexico
        • Intravenous Immunoglobulin Market by Application, 2017 - 2026
    6. Middle East & Africa
      1. Intravenous Immunoglobulin Market by Application, 2017 - 2026
  6. Company Profiles
    1. Baxter International Inc.
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
    2. CSL Ltd.
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
    3. Grifols S.A
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
    4. Octapharma AG
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
    5. Kedrion Biopharma Inc.
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
    6. LFB group
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
    7. Biotest AG
      1. Overview
      2. Financials
      3. Product Benchmarking
    8. China Biologics Products, Inc.
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
    9. BDI Pharma Inc.
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
    10. Bayer Healthcare
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments

 

Report Content

Qualitative Analysis

  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porter’s analysis
  • PESTEL analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Overview
    • Financials
    • Product benchmarking
    • Latest strategic developments

Quantitative Analysis

  • Market size, estimates, and forecasts from 2017 to 2026
  • Market revenue estimates for application up to 2026
  • Market revenue estimates for up to 2026
  • Regional market size and forecast for application from 2017 to 2026
  • Company financials

Request For customization

 

By using this form you agree with the storage and handling of your data by this website.

Speak to Analyst

 

By using this form you agree with the storage and handling of your data by this website.

Inquire Before Buying

 

By using this form you agree with the storage and handling of your data by this website.

Request for Sample

By using this form you agree with the storage and handling of your data by this website.